Irvine Dry Powder Media Facility
Source: MilliporeSigma
Our Dry Powder Media manufacturing facility located in Irvine, Scotland completes a Capital Expansion Plan initiated as part of its long-term commitment to supporting customers in the growing industrial biopharmaceutical market. The purpose-built facility produces animal component free media and offers regional support to the European market along with manufacturing redundancy to its North American sister facility in Lenexa, Kansas. This document presents details of the validation strategy for the new facility and an overview of the harmonization approach to ensure comparability with the Lenexa plant. #Biopharm
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more